Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
Clinical trial NCT05442710 · RECRUITING
Trial details
- NCT number
- NCT05442710
- Sponsor
- Artcline GmbH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-24
- Primary completion
- 2026-03-30
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.